Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CYP17A1 T-34C polymorphism is not associated with endometrial cancer risk.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Oct 2013

Yang Xueying, Feng Aihua, Liu Fengying, Li Qun, Zhang Jing, Yang Chuanhua, An Yujun

Abstract excerpt

The association between CYP17A1 T-34C polymorphism and endometrial cancer risk has been inconsistent and underpowered. To clarify the effect of CYP17A1 T-34C polymorphism on the risk of endometrial cancer, a meta-analysis of all available studies relating CYP17A1 T-34C polymorphism to the risk of endometrial cancer was conducted. The authors searched PubMed, EMBASE, Scopus, and VisionCite databases updated on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Endometrial Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Association Studies

Share to Genetic Predisposition to Disease

Share to Odds Ratio

Share to Polymorphism, Single Nucleotide

Share to Risk Factors

Share to Steroid 17-alpha-Hydroxylase

Source

Identifiers

PMID: 23609033
DOI: 10.1007/s13277-013-0805-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CYP17A1 T-34C polymorphism is not associated with endometrial cancer risk.PMID 23609033Read ↗

Genetic variation in CYP17 and endometrial cancer risk.Semantic proximity Read ↗

No association between CYP17 T-34C polymorphism and breast cancer risk: a meta-analysis involving 58,814 subjects.Semantic proximity Read ↗

Quantitative assessment of the association between CYP1A1 A4889G polymorphism and endometrial cancer risk.Semantic proximity Read ↗

Genetic variation of the CYP17 and susceptibility to endometrial cancer: a meta-analysis.Semantic proximity Read ↗

No association between the CYP1B1 C4326G polymorphism and endometrial cancer risk: a meta-analysis.Semantic proximity Read ↗

Association between cytochrome P450 1A1 MspI polymorphism and endometrial cancer risk: a meta-analysis.Semantic proximity Read ↗

Lack of association between the CYP1A1 Ile462Val polymorphism and endometrial cancer risk: a meta-analysis.Semantic proximity Read ↗

Association study between CYP17 gene polymorphism and endometriosis risk: a meta-analysis.Semantic proximity Read ↗

No association between MTHFR 677 C->T or 1298 A->C polymorphisms and endometrial cancer risk.Semantic proximity Read ↗

Association of CYP1B1 gene polymorphisms with susceptibility to endometrial cancer: a meta-analysis.Semantic proximity Read ↗

CYP17 genetic polymorphism in patients with endometrial hyperplasia and cancer.Semantic proximity Read ↗

The CYP17 MspA1 polymorphism is not associated with an increased risk of uterine leiomyomas in a Japanese population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.